According to a soon to be released market study, over 1 million new cannabis consumers will enter the Canadian marijuana market thanks to the sale of edibles.

At the fifth annual Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) Cannabis Expo, held last week in Toronto, there was much talk among attendees about the next stage of the legal Canadian market, which industry members are already calling “Cannabis 2.0.”

In a presentation at the show, Lift Chief Revenue Officer Jon Kamin and EY Strategic Growth and Risk Leader Ashley Chiu explained that the legalization of edibles is slated to be prolific and widespread.

Chiu said the study projects the entry of 1.5 million new consumers as Canadians gain the option to buy these alternative products.

The Canadian government is set to deliver legislation on the sale of edible products on or before October 17. However, it remains to be seen if actual sales will happen before the end of the year.

“One and a half million consumers are waiting for edibles to arrive,” the researcher said. She and Kamin see the introduction of edibles as a crucial step in advancing the cannabis narrative.

“Edibles will bring down the barriers of consumption,” Chiu said during her presentation.

During the Lift Cannabis Business Conference, a one day event at the expo, Vivien Azer, managing director for consumer research in the beverages, cannabis and tobacco markets for Cowen (NASDAQ:COWN), predicted that no edibles sales will take place in 2019 in Canada.

Researchers offer new consumer breakdown for edible consumption

To better understand how the market will be divvied up once edibles begin selling, Kamin and Chiu broke down the consumer sector into two groups: cannabis consumers and non-consumers.

They further broke down consumers into four categories: canna-savvy, canna-casual, canna-curious and the unconvinced.

Most people believe that the canna-savvy, people who are well versed in existing products and most likely used them before the first round of legalization last October, are the target group for the entire edibles space, but in actuality they are not.

The canna-savvy make up roughly 10 percent of the Canadian adult population, a percentage that is much smaller than what will be needed to help companies grow and appease shareholders.

Kamin added that the unconvinced are likely to never change their minds, and probably even opposed legalization in the first place. They are essentially pointless to the market.

The canna-curious, people who have never used cannabis but are interested, make up a much larger group of potential customers and are the people edibles companies need to be targeting, the researchers said.

Canna-curious consumers comprise 23 percent of the Canadian adult segment and are likely to try novel cannabidiol products, topical treatments and edibles.

This provides a unique opportunity for growers, retailers and marijuana store employees to reach an untapped market through education and information.

Cannabis specialists working in stores will guide curious and new consumers

The panelists explained that four out of 10 cannabis store employees said they would recommend a particular brand of product based on meetings with producers to understand their products’ aims.

The average canna-curious consumer is unaware of what types of products are available or what products they may want. Kamin said that as many as 70 percent of current dispensary visitors have no idea what they are going to purchase before entering a store.

Store employees, known as “budtenders,” are guaranteed to play a crucial role in the legal edibles market since the majority of people in the canna-curious consumer group will enter a dispensary with little to no knowledge of what they want to buy.

Data collected by EY and Lift on the top three questions asked of budtenders shows that 87 percent were asked about the difference between sativa, indica and hybrid.

Seventy-nine percent of the time, they were asked about the specific effects of an item and for product recommendations, including questions such as which strain will help induce sleep and which product aids in relaxation.

While the canna-savvy and the canna-casual — the two groups most comfortable and familiar with cannabis consumption — rely on preference, history and word of mouth, the canna-curious are more likely to trust a healthcare professional’s word when it comes to which products, strains and delivery methods to choose.

In fact, the report found that almost half of the canna-curious say recommendations from healthcare practitioners are very important to them.

These new users are also less likely to purchase online, opting for a face-to-face encounter.

Access to good, relevant information will be key in getting the canna-curious to convert to canna-casual or even canna-savvy, the researchers said.

Chiu and Kamin added that getting the work done ahead of October legalization is also paramount to ensuring that the curious user does not have a negative experience that puts them off cannabis use entirely.

“If we’re able to target (the 1.5 million new consumers) and provide the right amount of education to them, and make it specific to that consumer segment, I think it’s going to be a lot more effective than (broad) marketing techniques,” Chiu said.

Chiu told the Investing News Network the full report will be publicly released in the coming weeks.

Don’t forget to follow us @INN_Resource for real-time updates!

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) (“Curaleaf” or the “Company”) a leading U.S. provider of consumer products in cannabis, today announced that Boris Jordan Curaleaf Executive Chairman, and Sarah-Marie Cole Curaleaf Regional Vice President of Marketing, will be presenting at the Benzinga Cannabis Capital Conference on February 25, 2021 .

  • Boris Jordan , Executive Chairman, will be the opening keynote speaker for the Conference on February 25, 2021 at 9:10 am EST . The discussion will be moderated by Jason Raznick , Benzinga Chief Executive Officer.
  • Sarah-Marie Cole , Regional Vice President of Marketing, will be participating in the How to Reach Cannabis Consumers panel on February 25, 2021 at 2:05 pm EST . The panel will be moderated by Neal Hamilton , Benzinga Vice President of Marketing.

Webcast access details can be found on the Curaleaf IR website at .

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced an article covering FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF).

Cannot view this image? Visit:

Keep reading... Show less

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on Lobe Sciences Ltd. (OTC PINK:GTSIF) (CSE:LOBE). Lobe Sciences is a life sciences company focused on psychedelic medicines. To view the new research report, along with disclosures and disclaimers, or to download it in its entirety, please visit https:bit.ly3dIWXKe

Lobe Sciences is a life sciences company focused on psychedelic medicines and drug delivery to treat unmet needs representing multi-billion-dollar markets. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

Keep reading... Show less